SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+2.03%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$111M
AUM Growth
+$111M
(+44%)
Cap. Flow
+$33.2M
Cap. Flow
% of AUM
30.03%
Top 10 Holdings %
Top 10 Hldgs %
51.67%
Holding
118
New
41
Increased
16
Reduced
10
Closed
22
Top Buys
| 1 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$6.76M |
| 2 |
AstraZeneca
AZN
|
$6.39M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$4.25M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$4.12M |
| 5 |
Rockwell Medical
RMTI
|
$3.85M |
Top Sells
| 1 |
Biogen
BIIB
|
$16.8M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
$10.7M |
| 3 |
Xeris Biopharma Holdings
XERS
|
$2.89M |
| 4 |
PLLL
Piedmont Lithium Limited American Depositary Receipts
PLLL
|
$2.88M |
| 5 |
ALNA
Allena Pharmaceuticals, Inc. Common Stock
ALNA
|
$2.42M |
Sector Composition
| 1 | Healthcare | 73.93% |
| 2 | Technology | 3.83% |
| 3 | Industrials | 3.27% |
| 4 | Communication Services | 2.49% |
| 5 | Consumer Staples | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$19.4B
| $12.6M | 1.89% | 44,536 -59,366 | -57% | -$16.8M |
|
2
Moderna
MRNA
$9.37B
| $8.63M | 1.29% | 121,975 +50,082 | +70% | +$3.54M |
|
|
3
AstraZeneca
AZN
$248B
| $8.11M | 1.21% | 147,945 +116,625 | +372% | +$6.39M |
|
|
SRNE
4
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $6.76M | 1.01% | +606,298 | New | +$6.76M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $4.25M | 0.63% | +50,000 | New | +$4.25M |
|
|
6
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.12M | 0.62% | +99,921 | New | +$4.12M |
|
|
7
Rockwell Medical
RMTI
$58.9M
| $3.85M | 0.57% | +3,595,415 | New | +$3.85M |
|
|
SPI
8
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $3.07M | 0.46% | +425,762 | New | +$3.07M |
|
|
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.95M | 0.44% | +115,000 | New | +$2.95M |
|
10
Cineverse
CNVS
$93.3M
| $2.76M | 0.41% | +4,875,949 | New | +$2.75M |
|
|
CKPT
11
DELISTED
Checkpoint Therapeutics
CKPT
| $2.5M | 0.37% | +931,240 | New | +$2.5M |
|
12
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$262M
| $2.49M | 0.37% | +100,000 | New | +$2.49M |
|
13
Cocrystal Pharma
COCP
$15.4M
| $2.48M | 0.37% | +2,667,293 | New | +$2.48M |
|
14
Seanergy Maritime Holdings
SHIP
$163M
| $2.44M | 0.36% | +5,349,284 | New | +$2.44M |
|
15
XWELL
XWEL
$6.36M
| $2.35M | 0.35% | +1,191,233 | New | +$2.35M |
|
|
NMRD
16
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
| $2.18M | 0.33% | +613,765 | New | +$2.18M |
|
|
NVCN
17
DELISTED
Neovasc Inc.
NVCN
| $2.16M | 0.32% | 1,009,406 +683,383 | +210% | +$1.46M |
|
18
Pulmatrix
PULM
$18M
| $2.07M | 0.31% | 1,740,663 +1,728,719 | +14,474% | +$2.06M |
|
19
PainReform
PRFX
$2.92M
| $2.05M | 0.31% | +444,941 | New | +$2.05M |
|
|
BLU
20
DELISTED
BELLUS Health Inc.
BLU
| $2M | 0.3% | +880,400 | New | +$2M |
|
21
Daxor
DXR
$54.6M
| $1.93M | 0.29% | +122,406 | New | +$1.93M |
|
|
HYPD
22
Hyperion DeFi, Inc. Common Stock
HYPD
$34.7M
| $1.9M | 0.28% | +608,720 | New | +$1.9M |
|
|
CNTG
23
DELISTED
Centogene N.V. Common Shares
CNTG
| $1.72M | 0.26% | +182,275 | New | +$1.72M |
|
24
iShares Biotechnology ETF
IBB
$5.6B
| $1.54M | 0.23% | 11,372 +2,242 | +25% | +$304K |
|
|
AFIB
25
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $1.48M | 0.22% | +49,656 | New | +$1.48M |
|